Objective: Smokers who are not motivated to quit are an important group for intervention, particularly if they have children with asthma. Research indicates that unmotivated smokers are less responsive to intensive interventions, although motivation-by-treatment interactions have not been tested. This study examines whether motivation to quit moderates the effect of a cessation induction intervention. Method: Parents had an asthmatic child requiring urgent care, and did not have to want to quit smoking to be eligible for the study. Two home visits included asthma education, motivational interviewing (MI) for cessation, and feedback on child's secondhand smoke exposure (SHSe). Participants were then randomized (n ϭ 339, 79.6% female) to receive Enhanced-PAM (Precaution Adoption Model; 6 MI calls including SHSe feedback) or PAM (6 contact control calls). Motivation to quit was assessed at baseline and point-prevalence abstinence (ppa) and SHSe outcomes were objectively measured. Results: At baseline, 38.9% were not motivated to quit. Those who were not motivated to quit were 3 to 4 times more likely to be abstinent at 6 months in Enhanced-PAM versus PAM (7-day ppa: OR ϭ 3.71, 95% CI ϭ [1. 06, 12.99]; 30-day: OR ϭ 4.15, 95% CI [1.20, 14.35]); those receiving Enhanced-PAM achieved quit rates comparable to motivated smokers. Those who were not motivated to quit were more than 4 times as likely to have very low/undetectable SHSe at follow-up in Enhanced-PAM versus PAM (OR ϭ 4.46, 95% CI [1. 31, 15.15]). Among motivated smokers, neither outcome significantly differed by treatment arm. Conclusion: It cannot be assumed that smokers who are unmotivated to quit will not be responsive to intensive interventions.
days, excluding smokers who are not ready to quit. Studies have shown that smokers who are not motivated to quit are older, Caucasian, unemployed, smoke more cigarettes per day and are more likely to have used non-guideline-based approaches to quit smoking in their previous attempts versus smokers who are motivated to quit . Therefore, treatments are needed that show effectiveness in helping smokers who are not motivated to quit smoking.
Parents who smoke and are not motivated to quit smoking are an important group to target for intervention, given that secondhand smoke exposure (SHSe) increases the risk of pediatric asthma and other respiratory illnesses, otitis media, and poor cognitive development (Burke et al., 2012; Chen, Clifford, Lang, & Anstey, 2013) . SHSe also increases the likelihood that children will become smokers themselves (Kandel, Griesler, & Hu, 2015; Vuolo & Staff, 2013) . Despite reductions in overall smoking prevalence, parental smoking and pediatric SHSe remain high, particularly among minority and low-income families, and parents with children with asthma (Fedele et al., 2016; Kauffmann et al., 2010) .
Our previous randomized controlled trial enrolled parents who smoked and had a child with asthma regardless of their motivation to quit smoking . Parents who brought their child to urgent care due to an asthma exacerbation were recruited. They were told that they did not have to quit smoking in order to enroll in the study, but that they would have to agree to talk about their smoking as part of the asthma education that they would receive. Thus, asthma education was provided as a "foot in the door" to discuss the risks of smoking on their child's health and their own health. After receiving two home visits that included asthma education and motivational interviewing (MI) for cessation induction (which included biomarker feedback on the child's SHS and smoker's level of carbon monoxide), parents were randomized to receive either Enhanced-PAM (Precaution Adoption Model; continued MI for cessation induction and repeated SHSe feedback) or PAM (contact control calls that included a brief check on asthma status) during six phone calls over 4 months. Enhanced-PAM was significantly more likely to quit smoking than PAM at short and long term follow-ups.
The current paper is a secondary analysis of the data from this previous trial to test whether the effect of treatment condition is moderated by motivation to quit. To our knowledge, only one other study examined whether smoking cessation treatment was moderated by baseline motivation to quit, and this study was done with pregnant smokers, did not control for treatment intensity, and did not use MI (Aveyard et al., 2006) . Motivational interviewing is particularly well-suited for smokers who are not motivated to quit, given the emphasis on resolving ambivalence, building intrinsic motivation, and identifying how one's personal values are both helped and hindered by smoking (Borrelli, 2013) . Meta-analyses have shown that MI increases quit rates (Heckman, Egleston, & Hofmann, 2010; Lai, Cahill, Qin, & Tang, 2010) , and biomarker feedback on the health risks of smoking has been found to potentiate the effects of MI .
We hypothesized that motivation to quit within 30 days would moderate the effect of the intervention on smoking outcome and SHSe, such that smokers who were not motivated to quit within 30 days would be more likely to quit smoking and reduce SHSe with Enhanced-PAM versus PAM. On the other hand, we hypothesized that smokers who were motivated to quit within 30 days would be equally likely to quit smoking and reduce SHSe in either treatment condition. A rejection of the null hypothesis would suggest that more intensive, longitudinal treatments that use MI and repeated feedback are needed for smokers who are not motivated to quit, and that less resources may be used for interventions with smokers who are motivated to quit given their equal propensity to quit regardless of intervention intensity.
Our definition of motivated to quit within 30 days was used because (a) the literature has previously used imprecise definitions of unmotivated smokers (Carpenter et al., 2011; Davis et al., 2011), (b) this is the guideline that practitioners use to determine that the smoker is serious about quitting and recommend pharmacotherapy and behavioral counseling, (c) it corresponds to the voluminous literature on the "preparation" stage of change so that comparisons can be made with prior studies, (d) it has been used in the majority of systematic reviews and empirical articles (Asfar, Ebbert, Klesges, & Relyea, 2011) , and (e) it is consistent with the definition used in the U.S. Public Health Service (PHS, 2008) clinical practice guidelines.
Method

Sample and Participant Selection
Parents of children with asthma were recruited from emergency departments and urgent care centers in Rhode Island, U.S.A. Parents were eligible if they (a) were the primary caregiver Ն18 years of age (i.e., the person who spends the most time with the child and Ͼ4 hours per week), (b) have a child aged 3-17 years (asthma is difficult to diagnose in very young children), (c) smoked Ն3 cigarettes/day for the past year and Ͼ100 cigarettes in their lifetime (to ensure that the sample is comprised of "regular" smokers, rather than "occasional" smokers), (d) were not pregnant or planning to become pregnant, (e) spoke English, (f) had a telephone, and (g) were not currently enrolled in smoking cessation treatment. Parents of children who had other pulmonary disease (e.g., cystic fibrosis) were excluded. Prospective participants were told that they would be required to accept asthma education visits in their home and discuss their smoking, although they did not have to want to quit smoking to be enrolled in the trial. Informed consent was obtained in writing from all participants. The study was approved by our institution's human subjects review board.
Design
This paper is a secondary analysis from a larger study on motivating parents to quit smoking, which recruited a sample of parents who smoked and had a child with asthma, and a sample of parents who smoked and had healthy children . The current study utilizes only the sample of parents who smoked and had a child with asthma, because this group was the only group who were randomized to receive either a more intensive (Enhanced-PAM) or less intensive (PAM) smoking cessation intervention, a feature that is critical to testing the hypotheses proffered in the current study.
All participants who smoked and had a child with asthma received two, 1-hr home visits focused on asthma education and smoking cessation induction counseling. The asthma education was based on This document is copyrighted by the American Psychological Association or one of its allied publishers.
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NIH guidelines (NAEPP, 2007) . The smoking cessation induction counseling used motivational interviewing (Miller, 2002) After the two home visits, parents of children with asthma were randomized to either PAM or Enhanced-PAM (see Figure 1) ; both groups received six, 15-20-min calls regarding asthma symptoms and management for 4 months after the home visits. Calls were given twice per month (every other week) for the first 2 months and once per month for the last 2 months. For PAM participants, changes in asthma symptoms (daytime and nighttime) and asthma medications This article is intended solely for the personal use of the individual user and is not to be disseminated broadly.
were explored, as well as reasons for changes. The asthma management strategies previously discussed in Visits 1 and 2 were reviewed, and counseling regarding asthma management continued in MI style. PAM did not receive any smoking cessation counseling during the phone calls. Enhanced-PAM received a "check-in" on asthma symptoms and management, as well as strategies to help parents link their smoking to their child's asthma. This included continued MI for smoking cessation, including how smoking fits in with (or hinders) the smokers' values and goals, elicitation of change talk through strategic open-ended questions, and building readiness and confidence for change and, at the final phone call, a second round of SHSe feedback was given (to compare their child's current levels of SHSe with those obtained during the home visits). The number, duration, and timing of follow-up phone calls were identical for both Enhanced-PAM and PAM. Participants were offered 8 weeks of nicotine patch treatment at no cost if they were willing to set a quit date within 30 days.
Treatment Fidelity
We followed best practice guidelines for treatment fidelity (Borrelli, Sepinwall et al., 2005) . Trainers were licensed clinical psychologists, one certified in motivational interviewing and the other in asthma education. Counselors had graduate-level degrees and were trained using didactics, role-plays, and video. Skill acquisition was determined by intervention delivery with pilot participants. Counselors were guided by a written treatment protocol, sessions were audiotaped, and a random 20% were reviewed weekly with counselors. Sessions were coded using the Motivational Interviewing Treatment Integrity coding system (version 3.1.1; Moyers, Martin, Manuel, Miller, & Ernst, 2010) by three coders (blind to condition and outcomes) who completed 40 hours of training (e.g., coding standardized transcripts).
Measures
Smoking variables. Nicotine dependence was measured at baseline with the Fagerstrom Test for Nicotine Dependence (FTND), a valid and reliable scale to assess the degree of participant's nicotine dependence (Heatherton, Kozlowski, Frecker, & Fagerstrom, 1991) . Number of cigarettes smoked per day in the past week, total number of years smoked and the presence of household smoking ban (no smoking allowed anywhere in the home) were assessed by parent self-report.
Smoking status. Smoking status was assessed within 1 month of the last treatment call (4 months after baseline) and 2 months later (at the 6-month follow-up). Smoking status was assessed via self-report of no smoking, not even a puff, in the past 7 or 30 days (point prevalence abstinence [ppa]). Self-reported abstinence was verified using expired air carbon monoxide (Bedfont, CO Ecolyzer) at follow-up assessment. Abstinence was defined as CO Յ9 part per million (ppm; SRNT Subcommittee on Biochemical Verification, 2002). Continuous abstinence was defined as no smoking since the previous assessment.
Motivation. Motivation to quit was assessed at baseline with the question "Are you seriously thinking about quitting smoking"? The answer choices were "yes, within the next 30 days"; "yes, within the next 6 months" or "no, I am not thinking of quitting smoking." We considered those who endorsed "yes within 30 days" as motivated to quit. Endorsement to either "yes within the next 6 months" or "no, I am not thinking of quitting smoking" were classified as not motivated to quit. We collapsed these two groups for several reasons. Conceptually, the two groups ("I plan to quit within 6 months" and "I am not thinking of quitting") are similar because they represent smokers who are not committed to quitting smoking, either having a distal and vague goal to quit, or no plan to quit. Furthermore, there were no significant differences in abstinence rates between these two groups, providing further evidence to combine them. This categorical method of assessing motivation to quit is preferable to continuous measures because it avoids the need to choose arbitrary cut-off values (Abrams et al., 2003) .
Secondhand smoke exposure (SHSe). SHSe was assessed objectively using a passive nicotine monitor that uses nicotine as an index for SHSe (Hammond & Leaderer, 1987; Leaderer & Hammond, 1991) . One passive nicotine monitor was placed in the room in which the child spent the most time (home environment) and one was worn by the child (child environment). The monitor detects nicotine in the environment by passively collecting ambient smoke at a sampling rate of 24 ml/min. The monitors were analyzed by a chemistry laboratory blind to treatment condition using gas chromatography (Hammond & Leaderer, 1987) 
Analytic Plan
Analyses were performed with IBM SPSS Statistics version 20. Baseline differences in demographic variables between motivated and not motivated to quit groups were assessed using Analysis of Variance (ANOVA) for continuous variables and chi-square tests for categorical variables. The association between motivation and the cessation outcomes (7 and 30 day ppa, and continuous abstinence) was examined with a series of longitudinal regression models implemented with generalized estimating equations (GEEs) with robust standard errors (Hu & Lachin, 2001) . Analysis was performed on the intention-to-treat sample, thus including all randomized participants (missing ϭ smoking). Models allow for simultaneous testing of effects on outcomes at multiple time points. In this model, time was entered as a within-subjects factor whereas motivation to quit (yes vs. no) and treatment group (Enhanced-PAM vs. PAM) were entered as between-subjects categorical factors. Covariates included parent's age and sex, employment status and ethnicity that were selected due to significant differences between motivation groups on these variables as well as consistency with previously presented outcomes results . First, we specified a model that included a three-way interaction between motivation, treatment group, and time. Because the three-way interaction did not reach statistical significance, we tested only the interaction between motivation to quit and treatment group and adjusted for the (fixed) main effect of time.
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Unadjusted and adjusted parameter estimates for the main effects and interactions (B, SE and 95% CI) are presented in the results. Statistically significant interactions are interpreted as between-group comparisons (Enhanced-PAM vs. PAM) on the odds of being abstinent at end of treatment and at 6-month follow-up for the motivated and not-motivated subgroups and are expressed as odd ratios (ORs) with 95% CI.
Logistic regression models were used to examine the association between motivation to quit and objectively assessed SHSe in the home and child environment. At Step 1, the same covariates selected above were entered plus child's age and the proportion of households with a smoking ban. At Step 2, treatment group and motivation to quit were entered as predictors, and a treatment group-by-motivation to quit interaction was specified. Significant interactions were interpreted as between-group comparisons (Enhanced-PAM vs. PAM) on the odds of being in the very low/undetectable SHSe category at follow-up for the motivated and not-motivated group. Models additionally controlled for baseline value of the outcome (SHSe levels).
Results
Preliminary Analyses
Baseline demographics and smoking-related sample characteristics are summarized in Table 1 . There were 207 participants who reported motivation to quit within 30 days (61.1%) and 132 (38.9%) who were not motivated to quit within 30 days. Smokers who were motivated to quit were more likely to be employed ( 2 ϭ 4.74, df ϭ 1, p ϭ .03) and older (F 1,338 ϭ 8.41, p ϭ .004) compared to those who were not motivated to quit. Females were less likely to be motivated to quit ( 2 ϭ 4.74, df ϭ 1, p ϭ .03). There was no significant difference in the proportion of motivated and not-motivated participants by treatment group ( 2 ϭ 0.032, df ϭ 1, p ϭ .86). There were also no significant differences between those who were motivated to quit and those who were not motivated to quit in drop-out rates (motivated: 20.8% vs. notmotivated: 13.6%; 2 ϭ 2.78, df ϭ 1, p ϭ .09), home visit completion rates (home visit 1: 2 ϭ 0.43, df ϭ 1, p ϭ .51; home visit 2: 2 ϭ 0.64, df ϭ 1, p ϭ .42), or intervention dose as evidenced by phone calls received (Z ϭ Ϫ0.44, p ϭ .67). As expected, a greater proportion of smokers who were motivated to quit were sent nicotine patches (86.5%) and used these patches (64.7%) compared to smokers not motivated to quit (56.1% sent patches and 42.2% used patches; 2 ϭ 12.61, df ϭ 1, p ϭ .0004). There were no significant differences in 7-day ppa by use of nicotine patches at either end of treatment ( 2 ϭ 0.02, df ϭ 1, p ϭ .90) or at 6-months ( 2 ϭ 0.96, df ϭ 1, p ϭ .33). As reported in a previous paper, objectively coded data indicated satisfactory adherence to MI and there were no differences between treatment groups on treatment fidelity . Table 2 summarizes the unadjusted proportions of participants achieving abstinence at the 4-and 6-month endpoints by motivation to quit smoking in the two treatment groups. Regression models adjusted for covariates indicated that the group-bymotivation-by-time interaction was not significant (7-day ppa: Wald 2 ϭ 4.31, p ϭ .36; 30-day ppa: Wald 2 ϭ 6.80, p ϭ .15; continuous abstinence: Wald 2 ϭ 6.07, p ϭ .19); therefore, time was dropped from the interaction term and the models were refit.
Motivation to Quit and Smoking Cessation Outcomes
After adjusting for prespecified covariates, a significant motivation-by-treatment interaction was found for 7-day ppa, 30-day ppa, and continuous abstinence (see Table 3 ).
Among participants who were not motivated to quit, the odds of achieving 7-day ppa at follow-up were more than 3 times greater in Enhanced-PAM versus PAM (OR ϭ 3.71, 95% CI [1.06, 12.99]). The effects were stronger for 30-day ppa (OR ϭ 4.15, 95% CI [1.20, 14.35]) and continuous abstinence (OR ϭ 4.32, 95% CI [1.11, 16.87]). Importantly, among those not motivated to quit, Enhanced PAM had quit rates that were comparable to smokers who were motivated to quit (Table 2) . Among participants who were motivated to quit smoking, there were no significant differences between treatment groups in the odds of achieving 7-day ppa (OR ϭ 1.13, 95% CI [0.59, 2.18]) or 30-day ppa (OR ϭ 1.13, 95% CI [0.59, 2.17]) or continuous abstinence (OR ϭ 0.89, 95% CI [0.45, 1.76]). In the unadjusted model (see Table 3 ), a statistically significant interaction between motivation and treatment group This article is intended solely for the personal use of the individual user and is not to be disseminated broadly.
was observed for continuous abstinence and, marginally (p ϭ .053), for 30-day ppa, but not for 7 day ppa.
Motivation to Quit and Improvements in SHSe
Tables 4 and 5 summarize the unadjusted proportion of participants in each category of SHSe at baseline and follow-up for the home, and child environments, respectively, by motivation to quit in the two treatment conditions. There was a significant treatment group-by-motivation interaction (B ϭ 1.63, SE ϭ 0.75, p ϭ .03) for predicting home SHSe at follow-up. Among participants who were not motivated to quit smoking, the odds of being in the very low/undetectable category at follow-up for participants randomized to Enhanced-PAM were more than 4 times that of PAM (OR ϭ 4.46, 95% CI [1.31, 15.15]) after adjustment for baseline SHSe and the other study covariates.
Among motivated participants, there were no differences in the odds of having very low/undetectable levels of home SHSe at follow-up between treatment groups (OR ϭ 0.96, 95% CI [0.42, 2.23]). These was not a significant treatment group-by-motivation interaction for predicting the odds of having very low/undetectable levels of SHSe at follow-up in the child sampler environment (B ϭ 0.56, SE ϭ 0.69, p ϭ .41).
Discussion
Evidenced-based treatments are predominately designed for smokers who are ready to quit within 30 days. There is little guidance from research about what treatments are effective for smokers who are not ready to quit, particularly smokers who have a child with asthma. In the current study, parents of a child with asthma who were not motivated to quit smoking achieved better smoking cessation and SHSe outcomes with the more intensive intervention (Enhanced PAM) versus the less intensive intervention (PAM), whereas those who were motivated to quit smoking at study entry did not significantly differ in their outcomes by treatment group. Further, those who were not motivated to quit and received the more intensive intervention achieved cessation rates comparable to those who were motivated to quit. This suggests that interventions should be provided to smokers who have children with asthma, regardless of their motivation to quit. Intensive, longitudinal treatments that focus on cessation induction using MI and SHSe feedback may be needed to achieve smoking cessation outcomes among smokers who are not motivated to quit smoking. Our results are consistent with meta-analyses that have shown that MI is particularly effective for smokers who are not motivated to quit (Hettema & Hendricks, 2010) . To our knowledge, no previous studies have examined the interaction between motivation to quit and treatment condition.
Our results are opposite to those found by (Aveyard et al., 2006) , who found that women who were ready to quit smoking at baseline benefited more from motivational and intensive materials than women who were in earlier stages of change. The authors suggested that smokers "in preparation" for quitting may respond more favorably to interventions because they are primed and more interested to do so. However, that study was conducted with pregnant women, who may have different facilitators and barriers to quit smoking than the current sample. In addition, unlike the currently study, the Aveyard study did not control for contact time. Similarly, Danan and colleagues (2016) found that, among predominately male smokers in the VA, those who were in later stages of change were more likely to quit smoking with proactive outreach (telephone counseling, pharmacotherapy) than usual care, but these effects were not achieved by smokers in precontemplation.
Previous results support the use of MI with smokers who have children with asthma (Borrelli, McQuaid, Novak, Hammond, & Becker, 2010; Borrelli, McQuaid, et al., 2016) . The current study suggests that MI is also effective among smokers who are not motivated to quit and have a child with asthma. Our study employed several features that have been shown to be associated with larger effects of MI on smoking cessation: longer interventions, rigorous treatment fidelity, medical comorbidities, and inclusion of samples of smokers who are not motivated to quit (Hettema & Hendricks, 2010; Lai et al., 2010; Lindson-Hawley, Thompson, & Begh, 2015) . One meta-analysis (Hettema & Hendricks, 2010) found that studies that included samples with low levels of moti- This document is copyrighted by the American Psychological Association or one of its allied publishers.
vation had significant effects at both short-and long-term followups (d ϭ .39, d ϭ .34, respectively) as did those that included participants who were not required to be motivated to quit smoking at study enrollment (d ϭ .26). With regard to treatment fidelity, our study employed rigorous MI training, assessment of MI skill acquisition, ongoing skills maintenance and assessment of MI delivery using validated instruments. It is difficult to determine the effect of MI on smoking cessation on studies that do not employ treatment fidelity, and indeed, lower effects have been noted (Cook et al., 2016; Hettema & Hendricks, 2010) . One study tested the effect of MI on smokers who were not interested in quitting in the next 30 days and did not find an effect of MI, but the study did not measure treatment fidelity (Cook et al., 2016) . Several other approaches have been used to motivate smokers who are not motivated to quit. Practice quit attempts, sampling nicotine replacement (Carpenter et al., 2011) , and switching to e-cigarettes (Bullen et al., 2013) have been shown to lead to greater attempts to quit smoking among those not motivated to quit, but have not been shown to be associated with long-term biochemically confirmed abstinence. Future studies could also examine the effects of these interventions in smokers who are not motivated to quit and have children with asthma or other chronic respiratory illness. Note. PAM ϭ Precaution Adoption Model. This document is copyrighted by the American Psychological Association or one of its allied publishers.
A strength of our study is that we used proactive, rather than reactive recruitment. Reactive recruitment appeals to smokers who are highly motivated to quit, which constitutes a small percentage of the smoking population. Proactive recruitment of smokers reaches a larger percent of the population but generally achieves lower abstinence rates. The current study proactively recruited smokers and achieved quit rates that are in line with clinic-based interventions, despite having a sample that varied in their motivation to quit. At study entry, 38.9% of our sample was not motivated to quit within 30 days. This is a fairly large percentage, given that the children of the smokers were undergoing asthma exacerbations that required urgent care. In the current study, these unmotivated smokers achieved quit rates that are 2-3 times greater than the spontaneous quit rates noted in the literature (Fiore et al., 2008) . In a previous study of Latino parents who smoke and have children with asthma, the percent of parents who were unmotivated to quit at study entry was slightly higher (45%; Borrelli et al., 2010) , possibly due to several methodological factors (i.e., smokers were not solely recruited from urgent care as done in the current study, and the previous sample consisted only of Latino smokers; Borrelli et al., 2010) .
Over 60% of the participants in the current study said they wanted to quit smoking within 30 days. This is higher than previously found in studies with general smokers. National data show that 40% of current smokers are in the contemplation stage (thinking about quitting smoking within 6 months), 40% are in the precontemplation stage (not thinking about quitting smoking) and only 20% are in the preparation stage (planning to quit within 30-days; Etter et al., 1997) . More recent data indicate that about 30% of current smokers are "considering quitting within the next month" (Reid et al., 2014) . Our sample may have a higher percentage of smokers who want to quit possibly due to the context of a "teachable moment" (e.g., child in urgent care for an asthma exacerbation) that heightens the salience of risk of smoking and increases receptivity to messages about quitting smoking . "Readiness to quit" is typically higher among populations experiencing a teachable moment, such as parents who smoke and have a child with asthma, or smokers with medical comorbidities (Borrelli, Novak et al., 2005) .
With regard to secondhand smoke exposure, 63.4% of our sample reported that they had household smoking bans. While this may seem high, objective measurement has been shown to be a more accurate representation of smoke exposure, particularly among parents of children with asthma. One study found that parents of children with asthma were more likely to selfreport having household smoking bans than parents of healthy kids, but objective measurement of smoke exposure revealed equivalent levels of household smoke between the two groups (Borrelli, McQuaid, & Wagener, 2014) . Misrepresentation of smoke exposure could be a function of guilt about admitting exposure to their child (particularly if the child has asthma), or lack of knowledge. With regard to the latter, a parent might self-report a smoking ban in their home, but consider "smoking on the porch" as "not smoking in their home" (however, the smoke could drift into the house) or "smoking in a different room, away from the child" as "not smoking in their home." Parents also may have a general smoking ban in their home, but allow certain visitors or family to smoke in their homes (e.g., parent who is grateful that her mother will watch the children but doesn't want to ask her to not smoke). For these reasons, we used objective measurement of secondhand smoke exposure as an outcome variable in the study.
Studies are often limited by their ability to generalize to the larger population. The current study minimizes this bias by proactive recruitment and by offering smokers health education program for which they are highly motivated (asthma education regarding their child) during a teachable moment (the child's asthma exacerbation) so that smoking cessation induction could be woven into these sessions as an opportunity to link the child's health to their parent's behavior. Another possible limitation of our study is that the half-life of carbon monoxide is 4 -6 hours, so biochemical verification is limited to that time frame. Also, although the pattern of unadjusted proportions supported our hypotheses (see Table 2 ), the unadjusted regression models revealed that the motivation ϫ treatment interaction was significant (p Ͻ .05) or marginally significant (p ϭ .053) for two of the three smoking outcome variables, but the adjusted analyses revealed that the motivation ϫ treatment interaction was significant for all three smoking outcome variables. Therefore, the results should be interpreted with caution. A final limitation is that smoking status was not objectively verified at study entry. However, we have high confidence that those who admitted to smoking are actual smokers because smokers are usually reticent to admit smoking due to stigmatization or guilt, particularly parents of children with asthma.
Despite these limitations, all smokers who have children with asthma, regardless of their motivation to quit, should be offered intensive smoking cessation treatments over the longer term. It This document is copyrighted by the American Psychological Association or one of its allied publishers. This article is intended solely for the personal use of the individual user and is not to be disseminated broadly.
cannot be assumed that low motivation to quit means that smokers will not participate and will not respond to treatment. We believe that "the hook" for treatment engagement was offering asthma education during a teachable moment. The challenge for smoking cessation is to find "hooks" for other types of smokers who are not motivated to quit.
